Caricamento...
Rituximab for Refractory Rheumatoid Arthritis: A 24-Week Open-Label Prospective Study
OBJECTIVES: To study the efficacy of rituximab in active rheumatoid arthritis (RA) patients refractory to disease modifying anti-rheumatic drugs (DMARDs) including the tumor necrosis factor (TNF)-α antagonists. METHODS: Adult patients with active RA despite adequate therapies with conventional DMARD...
Salvato in:
| Autori principali: | , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Bentham Science Publishers Ltd.
2007
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2581826/ https://ncbi.nlm.nih.gov/pubmed/19088893 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1874312900701010001 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|